Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-062-9 | CAS number: 102-86-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 27 October 1987 to 18 December 1987
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- Non GLP, acceptable method but essential information in succint report
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 987
- Report date:
- 1987
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- yes
- Remarks:
- No certificate of analysis provided
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Trihexylamine
- EC Number:
- 203-062-9
- EC Name:
- Trihexylamine
- Cas Number:
- 102-86-3
- Molecular formula:
- C18H39N
- IUPAC Name:
- trihexylamine
- Test material form:
- liquid
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: not specified
- Expiration date of the lot/batch: not provided in the present report, the study mentionned "a detailed product characterization is included in the raw data"
- Purity test date: data not provided
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
No details on the test item was provided in the report, the study mentionned "a detailed product characterization is included in the raw data"
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: not specified
- Females (if applicable) nulliparous and non-pregnant:not applicable
- Age at study initiation: not specified
- Weight at study initiation: 171g
- Fasting period before study: the animals were fasted 16 hours before treatment
- Housing: stainless steel wire mesh cages
- Diet (e.g. ad libitum): Kliba-labordiaet 343, ad libitum
- Water (e.g. ad libitum): tap water ad libitum
- Acclimation period: at least 1 week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24 °C
- Humidity (%): 30 - 70 Relative humidy
- Air changes (per hr): Fully air conditioned rooms
- Photoperiod (hrs dark / hrs light): 12 hours / 12 hours (6:00 to 18:00 light period)
IN-LIFE DATES: not specified, euthanasia date : 11 November 1987
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- olive oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: test item at 43.00, 20.00 and 9.28 mg/L for, respectively, doses 2150, 100 and 464 mg/kg bw.
- Amount of vehicle (if gavage): 5 ml/kg
- Justification for choice of vehicle: the test item is insoluble in water
- Lot/batch no. (if required): not specifed
- Purity: not specified
MAXIMUM DOSE VOLUME APPLIED: 5 mL/kg
DOSAGE PREPARATION (if unusual): not specified - Doses:
- 464, 1000 and 2150 mg/kg
- No. of animals per sex per dose:
- 5 animals per sex per dose were used.
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Recording of signs and symptoms several times on the day of administration, at least once each workday. Check for moribund and dead animals twice each workday and once on holidays
- Necropsy of survivors performed: yes, withdrawal of food about 16 hours before sacrifice with CO2 : then necropsy with gross-pathological examination was performed. Necropsy all animals that die was assessed as early as possible
Results and discussion
Effect levelsopen allclose all
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- > 1 000 - < 2 150 mg/kg bw
- Based on:
- test mat. (total fraction)
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 000 mg/kg bw
- Based on:
- test mat.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 1 150 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: value from interpolation
- Mortality:
- Males : 1 animal died 2 days after exposure in high dose group, all animals of the high dose group died at 14 days.
Females : 2 animals died 2 days after exposure,all animals of the high dose group died at 14 days. 3 animals of the 1000 mg/kg group died after 7 days. - Clinical signs:
- Animals of all groups showed dysponea, apathy and piloerection at the low dose level. At medium dose, they additionnaly showed staggering and exsiccosis for male and females. At the high dose, they showed abnormal, atonia, paresis and spastic gait (this symptoms were present in the medium dose group for female animals)
- Body weight:
- no effect
Any other information on results incl. tables
Table 1 :Results for male rats
Doses (mg/kg) |
Number of animals |
Dead animals |
Mortality(%) |
464 |
5 |
0 |
0 |
1000 |
5 |
0 |
0 |
2150 |
5 |
5 |
100 |
Table2 :Results for female rats
Doses (mg/kg) |
Number of animals |
Dead animals |
Mortality(%) |
464 |
5 |
0 |
0 |
1000 |
5 |
3 |
60 |
2150 |
5 |
5 |
100 |
Table 3 : Results for male and females animals (pooled data)
Doses (mg/kg) |
Number of animals |
Dead animals |
Mortality(%) |
464 |
10 |
0 |
0 |
1000 |
10 |
3 |
30 |
2150 |
10 |
10 |
100 |
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- Based on the results, the LD50 of the test item tri-N-hexylamine was defined at 1150 mg/kg for rats by oral gavage. Hence, according to CLP criteria, the tri-n-hexylamine was classified Category 4 for acute oral hazard.
- Executive summary:
This non-GLP compliant study was assessed to evaluate the acute oral toxicity of the tri-N-hexylamine when administered in rats by gavage. The method was similar to OECD Guideline 401.
Female and male Wistar rats were used for this study. They were orally treated with 464, 1000 and 2150 mg/kg in single administration. 5 animals were used per condition and per sex. Clinical signs, symptoms and mortality were observed for 14 days.
Clinical signs were observed after treatment. Animals of all groups showed dyspnea, apathy and piloerection at the low dose level. At medium dose, they additionnaly showed staggering and exsiccosis for male and females. At the high dose, they showed abnormal, atonia, paresis and spastic gait (this symptoms were present in the medium dose group for female animals).
For males : 1 animal died 2 days after exposure in high dose group, all animals of the high dose group died at 14 days.
For females : 2 animals died 2 days after exposure,all animals of the high dose group died at 14 days. 3 animals of the 1000 mg/kg group died after 7 days
Based on the results, the LD50 of the test item tri-N-hexylamine was defined at 1150 mg/kg for rats by oral gavage. Hence, according to CLP criteria, the tri-n-hexylamine was classified Category 4 for acute oral hazard.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.